Axon Enterprise, INC Form 4 insider transactions
NASDAQ
Director Caitlin Elizabeth Kalinowski of Axon Enterprise, Inc. sold 800 shares of common stock on May 13, 2025, at a price of $713.25 per share.
NASDAQ
Director Matthew McBrady of Axon Enterprise, Inc. sold 400 shares of common stock at a weighted average price of $718.4043 on May 14, 2025.
NASDAQ
Axon Enterprise's President, Joshua Isner, executed multiple sales of common stock on May 12, 2025, at prices ranging from $667.21 to $701.67.
NASDAQ
Director Julie A. Cullivan sold 657 shares of Axon Enterprise, Inc. common stock at $700 per share on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Jeri Williams sold 657 shares of Axon Enterprise, Inc. common stock on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's CEO, Patrick W. Smith, sold shares of common stock on April 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, disposed of 1,250 shares of common stock on March 26, 2025, to cover tax liabilities from vesting restricted stock units.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, acquired 61,120 shares of common stock on March 24, 2025, related to performance-based restricted stock units.
NASDAQ
Joshua Isner, President of Axon Enterprise, reports acquiring and disposing of common stock related to performance-based restricted stock units.
NASDAQ
Axon Enterprise's CPO & CTO, Jeffrey Kunins, reports acquiring 41,236 shares of common stock and discloses details regarding performance-based restricted stock units.
NASDAQ
Axon Enterprise's CEO, Patrick W. Smith, acquired 194,030 shares of common stock on March 24, 2025, through the vesting of performance-based restricted stock units.
NASDAQ
Director Jeri Williams sold 307 shares of Axon Enterprise, Inc. common stock at a price of $552.72 per share on March 17, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Form 4: Axon Enterprise Director Sells $271,628 Worth of Stock Through Pre-arranged 10b5-1 Trading Plan
Axon Enterprise director Caitlin Elizabeth Kalinowski sold 450 shares of common stock on January 2, 2025, for a total of $271,628, according to a Form 4 filing with the SEC.
NASDAQ
Axon Enterprise's COO, Brittany Bagley, sold 1,272 shares of common stock to cover tax liabilities from vesting restricted stock units.
NASDAQ
Jeffrey Kunins, CPO & CTO of Axon Enterprise, reports the sale of common stock on December 23, 2024, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a total of 1,291 shares of common stock in multiple transactions, including shares withheld for tax obligations, as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a portion of his shares to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise CEO Patrick W. Smith gifted a total of 45,108 common shares to family trusts and a donor advised fund on December 13, 2024.
NASDAQ
Axon Enterprise director Michael Garnreiter sold 1,000 shares of common stock on December 16, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise, Inc. at an average price of $682.0596 on December 4, 2024.
NASDAQ
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a portion of his shares to cover tax obligations and pursuant to a pre-arranged trading plan.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a total of 3,780 shares of common stock between December 2nd and December 4th, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's COO & CFO, Brittany Bagley, sold 3,500 shares of common stock on November 22, 2024.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a total of 9,600 shares of common stock in multiple transactions on November 21, 2024.
NASDAQ
Matthew R. McBrady, a director at Axon Enterprise, sold a total of 1,000 shares of common stock in multiple transactions on November 20, 2024.
NASDAQ
Axon Enterprise's COO & CFO, Brittany Bagley, sold a total of 6,325 shares of common stock on November 15, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Michael Garnreiter, a director at Axon Enterprise, sold 1,000 shares of common stock at $599.53 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a total of 38,668 shares of common stock across multiple transactions on November 12th and 13th, 2024.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a significant number of shares and made a charitable donation of stock, according to a recent SEC filing.
NASDAQ
Director Michael Garnreiter of Axon Enterprise, Inc. executed a sale of 1,000 shares of common stock at a price of $437.98 per share on October 15, 2024, according to a Form 4 filing with the SEC.